Joydeep Goswami

Joydeep Goswami currently works at LGC Ltd., as President & Chief Executive Officer from 2025, BioLife Solutions, Inc., as Independent Director from 2021, TMune Therapeutics, Inc., as Director, OncoNano Medicine, Inc., as Director, and Life Technologies Japan Ltd., as President.
Dr. Goswami also formerly worked at Q Therapeutic Products, Inc., as Director, Q Therapeutics, Inc., as Director, Invitrogen Corp., as VP-Stem Cell & Regenerative Biology, McKinsey & Co., Inc., as Principal, Thermo Fisher Scientific, Inc., as President-Clinical Next Generation Sequencing from 2016 to 2019, Life Technologies Corp., as Vice President, and Illumina, Inc., as CFO, Chief Strategy & Development Officer from 2023 to 2024.
Dr. Goswami received his graduate degree, Masters Business Admin degree, and doctorate degree from Massachusetts Institute of Technology and undergraduate degree from Indian Institute of Technology Bombay.